The bacteria themselves appeared indifferent to persistence
Over two decades of genomic surveillance in England and Wales, scientists have found that the persistence of enteric fever in the body is not written in the bacteria's genes, but in the immune history of the person who carries them. The young and the elderly — those at the edges of immune resilience — are most likely to become silent, long-term reservoirs of a disease that continues to rise in incidence, reaching its highest point in 2023. The study quietly reorients the search for answers: the pathogen is not the protagonist of carriage; the host is.
- Enteric fever cases in England and Wales hit a twenty-year high in 2023, with 652 infections recorded — a disease that was never truly contained is visibly resurging.
- A small but consequential fraction of patients become carriers, shedding bacteria without symptoms and unknowingly exposing households and communities to infection for months or even years.
- Researchers sequenced hundreds of bacterial genomes searching for a microbial fingerprint of carriage and found almost nothing — the bacteria appear indifferent to whether they persist or are cleared.
- Age emerged as the decisive variable: children under ten and adults over eighty showed the highest odds of becoming carriers, pointing squarely at immune capacity as the governing factor.
- Current public health guidelines focus follow-up testing on food handlers and healthcare workers, but the data argue for a broader net — older adults and immunosuppressed individuals are the populations most at risk of becoming invisible transmission sources.
Over twenty years of tracking enteric fever across England and Wales, researchers arrived at a finding that inverts conventional assumptions: the bacteria themselves do not determine who becomes a long-term carrier. The UK Health Security Agency analyzed nearly ten thousand isolates from more than eight thousand patients between 2004 and 2023, documenting a disease that averages 415 cases per year but climbed to 652 in 2023 — its highest point in the study period. Cases follow seasonal rhythms, peaking in late summer and autumn, and the overwhelming majority trace back to travel, particularly to India and Pakistan, with South Asian communities visiting friends and relatives bearing a disproportionate share of the burden.
Of the infections analyzed, only 2.7 percent of patients became carriers — people who harbor the bacteria long after the acute illness resolves, often without knowing it. Chronic carriage lasting more than a year was rarer still, occurring in just 0.1 percent of cases. The age pattern was striking: children under ten and elderly patients in their eighties showed significantly elevated odds of persistent infection, while young adults in their twenties were the least likely to carry the bacteria. Vaccination, antibiotic treatment, deprivation level, and travel history explained nothing. Age — and by implication, immune capacity — explained nearly everything.
To test whether certain bacterial strains were predisposed to cause carriage, researchers sequenced genomes from nearly half their isolates and mapped them phylogenetically. Carriage cases appeared scattered at random across the bacterial family tree, with no clustering by strain type, geography, or era. One minor exception surfaced among Paratyphi B isolates from South America, but it only reinforced the broader conclusion: the pathogen is not driving carriage. The host immune system is.
The public health implications are pointed. Current UK guidelines recommend post-treatment monitoring mainly for food handlers, healthcare workers, and children. The study makes the case for expanding that net to include older adults and immunosuppressed individuals — the populations most likely to become silent, long-term transmitters. One documented case in the study showed a carrier infecting household members with genetically distinct strains more than a decade after the original infection, a quiet reminder of what goes unseen when follow-up is too narrow.
Over twenty years, researchers tracking enteric fever across England and Wales uncovered something counterintuitive: the bacteria themselves don't seem to determine who becomes a long-term carrier. Instead, it's the patient's immune system that holds the key.
The UK Health Security Agency collected nearly ten thousand bacterial isolates between 2004 and 2023, mostly from blood or stool samples. These came from 8,335 patients, and the numbers tell a story of a disease that remains stubbornly present. On average, 415 cases were reported annually, but by 2023, that figure had climbed to 652—the highest count in the entire two-decade span. The disease follows predictable patterns: cases spike in late summer and early autumn, and the vast majority of infections trace back to travel, particularly to India and Pakistan. More than four in five patients with South Asian heritage who contracted typhoid had traveled to visit friends or relatives in their ancestral regions.
What makes this study distinctive is its focus on carriage—the phenomenon where someone harbors the bacteria long-term, often without symptoms, becoming an unwitting vector for transmission. Among the 8,297 unique infections analyzed, only 224 patients (2.7 percent) became carriers. Of those, the vast majority experienced brief carriage lasting weeks rather than months. Chronic carriers, those harboring the bacteria for more than a year, represented just 0.1 percent of all cases. The pattern was striking: children aged zero to ten and elderly patients aged eighty-one to ninety showed significantly elevated odds of becoming carriers, while young adults in their twenties showed the opposite—they were far less likely to develop persistent infection.
The researchers then sequenced the bacterial genomes from nearly half their isolates, hunting for genetic signatures that might predispose certain strains to cause carriage rather than acute illness. They found almost none. Across the phylogenetic trees they constructed, carriage isolates were scattered randomly throughout, showing no clustering by genetic type, geographic origin, or time period. The bacteria themselves appeared indifferent to whether they would persist in a host or be cleared. One small exception emerged: a handful of Paratyphi B isolates from South America showed a slight tendency toward carriage, but this was the exception proving the rule.
Other factors that might logically influence carriage—vaccination status, antibiotic choice, deprivation level—showed no meaningful correlation with who became a carrier. Patients who received antibiotics were just as likely to become carriers as those who didn't. The type of antibiotic made no difference. Vaccination offered no protection against carriage, only against acute infection. The researchers controlled for travel history, ethnicity, sex, and socioeconomic status. None of these variables explained the carriage pattern. What remained was age: the young and the old, the immunologically naive and the immunologically waning, were the ones most likely to harbor persistent infection.
The implications shift the focus of future research away from the pathogen and toward the host. If bacterial genetics don't drive carriage, then understanding why some immune systems fail to clear the infection while others succeed becomes paramount. The study notes that similar patterns have been observed with other bacteria—HIV-positive patients carry Staphylococcus aureus at higher rates, and very young children show extended colonization with pneumococcus. The pattern is consistent: immune capacity matters more than microbial genetics.
For public health, the findings suggest that current guidelines are too narrow. The UK Health Security Agency currently recommends follow-up testing only for high-risk groups like food handlers, healthcare workers, and children. The study argues for expansion: older adults, immunosuppressed individuals, and those without recent travel history should also be monitored after treatment. These are the populations most likely to become the modern-day typhoid Marys—people who unknowingly shed bacteria into their communities, as happened in one documented case where a carrier infected household members with genetically distinct strains more than a decade after acquiring the infection in Pakistan. Without systematic follow-up, such carriers remain invisible until they transmit disease to others.
Citações Notáveis
Host factors, specifically those related to the immune system, may have a greater influence on infection persistence than bacterial genetics— Study authors, discussing carriage mechanisms
Patients aged 21-30 had 35% lower odds of becoming carriers, while those aged 81-90 had over 447% higher odds— Statistical analysis from the study
A Conversa do Hearth Outra perspectiva sobre a história
Why does age matter so much here? What's different about an eighty-year-old's immune system compared to someone in their twenties?
The study doesn't answer that directly, but the pattern is clear—immunosenescence in the elderly and immune naivety in young children both create vulnerability. The body loses its ability to mount certain responses as it ages, and children haven't yet built up their defenses. A healthy adult in their twenties has a mature, primed immune system that can clear the infection. The bacteria don't change; the host's capacity to fight it does.
So if it's not the bacteria, why did researchers sequence all those genomes? What were they looking for?
They were testing the obvious hypothesis—that certain strains might be inherently "stickier," more prone to persistence. It's reasonable to ask whether the bacteria have evolved tricks to hide in the gallbladder longer. But they found almost nothing. The carriage isolates are scattered across the entire family tree, mixed in with acute-infection strains. That negative result is actually the important finding. It tells us the problem isn't in the microbe's playbook.
The study mentions "modern-day typhoid Marys." How dangerous are these carriers in practice?
They're a persistent, low-level threat in a place like England where typhoid is rare. One case involved a carrier who'd been infected over a decade earlier in Pakistan, living quietly in the UK, shedding bacteria intermittently. When household members got infected, they had different bacterial strains—proof the carrier was harboring a diverse population. Without surveillance, no one would have known. In endemic regions, carriers are a known problem. Here, they're invisible until they cause a cluster.
Why would someone not travel be more likely to become a carrier?
The researchers think it's about population immunity. In England and Wales, most people have never encountered typhoid bacteria. If someone gets infected locally—from a returning traveler or a carrier—their immune system has no prior experience with this pathogen. They're immunologically naive to it, just like the children in the study. That naivety may make persistent infection more likely.
The study says vaccination didn't protect against carriage. Does that mean the vaccine is failing?
No—the vaccine prevents acute disease, which it does well. But it apparently doesn't prevent someone from becoming a carrier if they do get infected. That's a different problem. The vaccine stops you from getting sick; it doesn't necessarily stop you from harboring the bacteria long-term. That distinction matters for public health strategy.